ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NOXXON Pharma Enters Second Clinical Collaboration With MSD to Evaluate NOX-A12 in Combination With KEYTRUDA (Pembrolizumab) in Upcoming Phase 2 Pancreatic Cancer Study
July 22, 2021NOXXON today announced entering into its second clinical collaboration agreement with MSD (Merck & Co., Inc., Kenilworth, N.J. USA), to collaborate in the upcoming Phase 2 clinical trial of NOXXON's NOX-A12 in combination with MSD's anti-PD-1 therapy.
Pharma Sources Insight January 2025
